- Home
- BBNX
BBNX
Beta Bionics Inc. Common Stock
as 02-05-2025 1:32pm EST
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 973.6M | IPO Year: | 2025 |
| Target Price: | N/A | AVG Volume (30 days): | 2.3M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.89 | EPS Growth: | N/A |
| 52 Week Low/High: | $21.72 - $24.50 | Next Earning Date: | 01-01-0001 |
| Revenue: | $53,034,000 | Revenue Growth: | 6601.12% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Beta Bionics Inc. Common Stock News
BBNX Breaking Stock News: Dive into BBNX Ticker-Specific Updates for Smart Investing
GlobeNewswire
5 days ago
Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
MedTech Dive
5 days ago
Beta Bionics raises $204M in IPO
Medical Device Network
6 days ago
Beta Bionics raises $204m to kickstart medtech IPO season
MT Newswires
6 days ago
Beta Bionics Shares Rise in Nasdaq Debut
GlobeNewswire
7 days ago
Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering
Compare BBNX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BBNX Beta Bionics Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.